Charterhouse Partners With Tunstall for Future Growth

TunstallTunstall Group, the market leading provider of telecare and telehealth solutions, has undertaken an extensive strategic review of its business, and has found an excellent new partner in Charterhouse Capital Partners, further strengthening the Group's future growth plans.

Charterhouse is a successful British business with a 30-year track record and is committed to backing the Tunstall management team to achieve its vision. They join Bridgepoint, Tunstall's previous majority shareholder, who become a minority shareholder in the business.

Tunstall's solutions support over 2.5 million people worldwide allowing them to live independently, by effectively managing their health and well-being. Telecare is increasingly recognised as being at the heart of modern health and social care systems and Tunstall's aim is to deliver a broader range of services to effectively assist more people by providing flexible, timely, and proactive support.

James Buckley, Chief Executive, Tunstall Group said, "I am delighted to be working with Charterhouse to realise our vision of improving the quality of life for many more people in the future. Telecare plays a key role in delivering personalised care to support people with health and social care needs, their families and carers. Our aim is to offer even more enhanced levels of support, drive forward our technology plans and work with our customers to provide effective solutions for a diverse range of people across the globe and I believe we have found the right team to help us achieve our ambitions."

Jeremy Greenhalgh, Partner, Charterhouse added "It is clear that Tunstall is a very successful business with attractive solutions in a market that is experiencing ageing demographics and the emergence of lifestyle epidemics such as obesity and chronic disease. Governments around the world are recognising the compelling economics of telecare and telehealth and I am looking forward to working with the team to deliver its plans for the future."

Related news articles:

About Tunstall
Tunstall is the market leading provider of telecare and telehealth solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives. For more information on how telecare and telehealth can improve quality of life, visit www.tunstall.co.uk.

About Charterhouse
Charterhouse Capital Partners leads and invests in large European buy-outs and has been doing so since the early days of the buy-out market in the 1980's. With over 128 transactions, worth an aggregate €38bn in transaction value, and with 89% of those investments realised, we believe that our track record and experience combine to make us one of the most successful private equity firms in Europe. www.charterhouse.co.uk

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...